When will the US contact-tracing app be ready?
As the UK launches its new NHS Test and Trace app for COVID-19, the US is yet to get to grips with this vital part of handling exposure to the novel coronavirus
data
Evidation raises $45 million Series D
Evidation Health has closed a $45 million Series D financing round, led by B Capital Group. Marwaha joins as Chief Commercial Officer.
EU agrees COVID-19 contact tracing framework
EU member states agreed on technical specifications for the safe exchange of data between national contact tracing apps.
Kyruus takes $30 million more for patient access
Just five months after closing a $42 million Series D funding round, Kyruus has raised a further $30 million. The investment comes from private equity firm Francisco Partners.
Medopad makes AI acquisitions, rebrands to Huma
Huma is the new name for Medopad as it makes acquisitions in its quest to make preventative healthcare a reality.
C-19: symptom reporting app launched by King’s College London
King’s College London has launched a COVID-19 symptom-tracking app in the UK. The aim is to help slow the outbreak by tracking in real time: How fast the virus is spreading geographically High-risk areas in the UK Who is most at risk, by better understanding symptoms linked to underlying health conditions The app is free to […]
NHS England selects vendors for future healthcare
Electronic health record solutions must be interoperable and modular.
Digital transformation threatens data security at US healthcare organisations
Criminals target sensitive data left unencrypted after digital transformation initiatives
BioPharma Ledger brings blockchain to clinical trials
ALTEN Calsoft Labs launches blockchain clinical trial platform in partnership with clinical research organisation Clinlogix
MedCrypt raises $5.3 million as concerns for medtech cybersecurity grow
MedCrypt, a medical device cybersecurity software provider, has closed a Series A round of $5.3 million, led by Section 32, with participation from Eniac Ventures and Y Combinator. The funds will be used for sales and marketing, and for product development.